Beau Webber
21Patents
5h-index
19Co-inventors
58Inventor score
Filing activity: Jul 29, 2016 → Mar 10, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10166255B2 | Intracellular genomic transplant and methods of therapy | Chemistry; Metallurgy | 39 | Active |
| US10406177B2 | Modified cells and methods of therapy | Chemistry; Metallurgy | 11 | Active |
| US10912797B2 | Tumor infiltrating lymphocytes and methods of therapy | Chemistry; Metallurgy | 9 | Active |
| US11154574B2 | Tumor infiltrating lymphocytes and methods of therapy | Chemistry; Metallurgy | 8 | Active |
| US11147837B2 | Modified cells and methods of therapy | Chemistry; Metallurgy | 5 | Active |
| US11266692B2 | Intracellular genomic transplant and methods of therapy | Chemistry; Metallurgy | 3 | Active |
| US10227574B2 | Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods | Chemistry; Metallurgy | 3 | Active |
| US11760983B2 | Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods | Chemistry; Metallurgy | 0 | Active |
| US11583556B2 | Modified cells and methods of therapy | Chemistry; Metallurgy | 0 | Active |
| US11278570B2 | Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods | Chemistry; Metallurgy | 0 | Active |
| US11111483B2 | Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems and methods | Chemistry; Metallurgy | 0 | Active |
| US12097220B2 | Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods | Chemistry; Metallurgy | 0 | Active |
| US11925664B2 | Intracellular genomic transplant and methods of therapy | Chemistry; Metallurgy | 0 | Active |
| US12037611B2 | Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods | Chemistry; Metallurgy | 0 | Active |
| US11642374B2 | Intracellular genomic transplant and methods of therapy | Chemistry; Metallurgy | 0 | Active |
| US12270050B2 | Human T cell derived from T cell-derived induced pluripotent stem cell and methods of making and using | Chemistry; Metallurgy | 0 | Active |
| US10648002B2 | Method for correcting a genetic sequence | Chemistry; Metallurgy | 0 | Active |
| US12281327B2 | Lymphohematopoietic engineering using CAS9 base editors | Chemistry; Metallurgy | 0 | Active |
| US11162084B2 | Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods | Chemistry; Metallurgy | 0 | Active |
| US11903966B2 | Intracellular genomic transplant and methods of therapy | Chemistry; Metallurgy | 0 | Active |
| US11642375B2 | Intracellular genomic transplant and methods of therapy | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.